Germ cell defects and hematopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the fanconi anemia C gene

Blood

Volumn 88, Issue 1, 1996, Pages 49-58

  Whitney, Michael A ^b   Royle, Gordon ^b   Low, Malcolm J ^b   Kelly, Michele A ^b   Axthelm, Michael K ^b   Reifsteck, Carol ^b   Olson, Susan ^b   Braun, Robert E ^b   Heinrich, Michael C ^b   Rathbun, R Keaney ^b   Bagby, Grover C ^b   Grompe, Markus ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DNA CROSS LINKING; DOSE RESPONSE; EMBRYO; FANCONI ANEMIA; FEMALE; FERTILITY; GENE DELETION; GERM CELL; HEMATOPOIESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETON MALFORMATION;

EID: 8944258558     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.49.bloodjournal88149     Document Type: Article

References (53)

1. Billardon B, Moustacchi E: Comparison of the sensitivity of Fanconi's anemia and normal fibroblasts of sister-chromatic exchanges by photoaddition of mono- and bi-functional psoralens. Mutat Res 174:241, 1986
2. Seyschab H, Sun Y, Friedl R, Schindler D, Hoehn H: G2 phase cell cycle disturbance as a manifestation of genetic cell damage. Hum Genet 92:61, 1993
3. Cohen MM, Fruchtman CE, Simpson SD, Martin AO: The cytogenetic response of Fanconi's anemia lymphoblastoid cell lines to various clastogens. Cytogenet Cell Genet 34:230, 1982
4. Schindler D, Hoehn H: Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet 43:429, 1988
5. Saito H, Hammond AT, Moses RE: Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. Mutat Res 294:255, 1993
6. Fanconi G: Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.) I. Clinical aspects. Semin Hematol 4:233-240, 1967
7. Auerbach AD, Rogatko A, Schroeder-Kurth TM: International Fanconi Anemia Registry: Relation of clinical symptoms to diepoxybutane sensitivity. Blood 73:391, 1989
8. Alter BP, Tenner MS: Brain tumors in patients with Fanconi's anemia. Arch Pediatr Adolesc Med 148:661, 1994
9. Heim RA, Lench NJ, Swift M: Heterozygous manifestations in four autosomal recessive human cancer-prone syndromes: Ataxia telangiectasia, xeroderma pigmentosum, Fanconi anemia, and Bloom syndrome. Mutat Res 284:25, 1992
10. Allen C, Meyn MS: A low threshold for mutagen induced apoptosis in Fanconi anemia cells. Am J Hum Genet 57: abstract 232, 1995 (Suppl)
11. Alter BP: Fanconi's anemia. Current concepts. Am J Pediatr Hematol Oncol 14:170, 1992
12. Strathdee CA, Duncan AM, Buchwald M: Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1:196, 1992
13. Duckworth-Rysiecki G, Cornish K, Clarke CA, Buchwald M: Identification of two complementation groups in Fanconi anemia. Somat Cell Mol Genet 11:35, 1985
14. Joenje H, Lo-ten-Foe JR, Oostra AB, van-Berkel CG, Rooimans MA, Schroeder-Kurth T, Wegner RD, Gille JJ, Buchwald M, Arwert F: Classification of Fanconi anemia patients by complementation analysis: Evidence for a fifth genetic subtype. Blood 86:2156, 1995
15. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 358:434, 1992
16. Wevrick R, Clarke CA, Buchwald M: Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genetics 2:655, 1993
17. Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach R, Naylor S, Joenje H, Grompe M: Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet 11:341, 1995
18. Pronk JC, Gibson RA, Savoia A, Wijker M, Morgan NV, Melchionda S, Ford D, Temtamy S, Ortega JJ, Jansen S, Havenga C, Cohn RJ, de Ravel TJ, Roberts I, Westerveld A, Easton DF, Joenje H, Mathew CG, Arvert F: Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nat Genet 11:338, 1995
19. Buchwald M: Complementation groups: one or more per gene? Nat Genet 11:228, 1995
20. Youssoufian H: Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 91:7975-9, 1994
21. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD: The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 91:6712, 1994
22. Youssoufian H, Auerbach AD, Verlander PC, Steimle V, Mach B: Identification of cytosolic proteins that bind to the Fanconi anemia complementation group C polypeptide in vitro. Evidence for a multimeric complex. J Biol Chem 270:9876, 1995
23. Whitney MA, Saito H, Jakobs PM, Gibson RA, Moses RE, Grompe M: A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. Nat Genet 4:202, 1993
24. Verlander PC, Lin JD, Udono MU, Zhang Q, Gibson RA, Mathew CG, Auerbach AD: Mutation analysis of the Fanconi anemia gene FACC. Am J Hum Genet 54:595, 1994
25. Gavish H, dos-Santos CC, Buchwald M: A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein. Hum Mol Genet 2:123, 1993
26. Gibson RA, Hajianpour A, Murer-Orlando M, Buchwald M, Mathew CG: A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. Hum Mol Genet 2:797, 1993
27. Yamashita T, Wu N, Kupfer G, Corless C, Joenje H, Grompe M, D'Andrea AD: The clinical variability of Fanconi Anemia (type C) results from expression of an amino terminal truncated FAC polypeptide with partial activity. Blood 87:4424, 1996
28. Segal GM, Magenis RE, Brown M, Keeble W, Smith TD, Heinrich MC, Bagby GC Jr: Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest 94:846, 1994
29. Walsh CE, Grompe M, Vanin E, Buchwald M, Young NS, Nienhuis AW, Liu JM: A functionally active retrovirus vector for gene therapy in Fanconi anemia group C. Blood 84:453-9, 1994
30. Soriano P, Montgomery C, Geske R, Bradley A: Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693, 1991
31. Ram'irez-Solis R, Rivera-P'erez J, Wallace JD, Wims M, Zheng H, Bradley A: Genomic DNA microextraction: a method to screen numerous samples. Anal Biochem 201:331, 1992
32. Bradley A: Production and analysis of chimaeric mice, in Robertson EJ (eds): Teratocarcinomas and Embryonic Stem Cells. A Practical Approach. Oxford, UK, IRL, 1987, p 113
33. Mullis KB, Faloona FA: Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155:335, 1987
34. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
35. Kogan SC, Doherty M, Gitschier J: An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences: application to hemophilia A. N Engl J Med 317:985, 1987
36. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
37. Kallioniemi OP, Visakorpi T, Holli K, Isola JJ, Rabinovitch PS: Automated peak detection and cell cycle analysis of flow cytometric DNA histograms. Cytometry 16:250, 1994
38. Dorin JR, Stevenson BJ, Fleming S, Alton EW, Dickinson P, Porteous DJ: Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mamm Genome 5:465-72, 1994
39. Sasaki MS: Is Fanconi's anaemia defective in a process essential to the repair of DNA cross links? Nature 257:501-3, 1975
40. Berger R, Le-Coniat M, Gendron MC: Fanconi anemia. Chromosome breakage and cell cycle studies. Cancer Genet Cytogenet 69:13-6, 1993
41. Dutrillaux B, Aurias A, Dutrillaux AM, Buriot D, Prieur M: The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 62:327-32, 1982
42. Alter BP: Hematologic abnormalities in Fanconi anemia. Blood 85:1148-9, 1995
43. Alter BP, Knobloch ME, Weinberg RS: Erythropoiesis in Fanconi's anemia. Blood 78:602, 1991
44. Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM: Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector [see comments]. J Clin Invest 94:1440, 1994
45. Liu JM, Buchwald M, Walsh CE, Young NS: Fanconi anemia and novel strategies for therapy. Blood 84:3995, 1994
46. Wang CQ, Udupa KB, Lipschitz DA: Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J Cell Physiol 162:134, 1995
47. Raefsky EL, Platanias LC, Zoumbos NC, Young NS: Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol 135:2507, 1985
48. Zoumbos NC, Gascon P, Djeu JY, Young NS: Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA 82:188, 1985
49. Maciejewski J, Selleri C, Anderson S, Young NS: Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
50. Baker SM, Bronner CE, Zhang L, Plug AW, Robatzek M, Warren G, Elliott EA, Yu J, Ashley T, Arnheim N, Flavell RA, Liskay RM: Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82:309, 1995
51. Silvers WK: The Coat Colors of Mice: A Model for Mammalian Gene Action and Interaction. New York, NY Springer-Verlag, 1979
52. Bedell MA, Brannan CI, Evans EP, Copeland NG, Jenkins NA, Donovan PJ: DNA rearrangements located over 100 kb 5′ of the Steel (SI)-coding region in Steel-panda and Steel-contrasted mice deregulate SI expression and cause female sterility by disrupting ovarian follicle development. Genes Dev 9:455-70, 1995
53. Pesce M, Farrace MG, Piacentini M, Dolci S, De-Felici M: Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 118:1089, 1993